Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
120 words
A test device for determining a ligand in, or the ligand binding capacity of, a test sample, the device comprising a support member having a substantially planar side, a carrier member affixed to the substantially planar side, the carrier member comprising a substantially bibulous material, and a reagent system homogeneously incorporated with, but not bound to, the carrier member, the reagent system comprising ingredients capable of participating in a specific binding assay and including a label conjugate and a specific binding partner to the conjugate and the ligand, the conjugate comprising a label bound to the ligand or a specific binding analogue thereof, the conjugate and specific binding partner therefor being present in the carrier substantially unbound to one another.
Claim 2
Dependent Claim
120 words
A test device for determining a ligand in, or the ligand binding capacity of, a test sample, the device comprising a support member having a substantially planar side, a carrier member affixed to the substantially planar side, the carrier member comprising a substantially bibulous material, and a reagent system homogeneously incorporated with, but not bound to, the carrier member, the reagent system comprising ingredients capable of participating in a specific binding assay and including a label conjugate and a specific binding partner to the conjugate and the ligand, the conjugate comprising a label bound to the ligand or a specific binding analogue thereof, the conjugate and specific binding partner therefor being present in the carrier substantially unbound to one another.
Claim 3
Dependent Claim
23 words
The test device of claim 1 in which the label conjugate is a fluor bound to the ligand or specific binding analogue thereof.
Claim 4
Dependent Claim
13 words
The test device of claim 1 in which the label conjugate is unbelliferone-ligand.
Claim 5
Dependent Claim
23 words
The test device of claim 1 in which the reagent system additionally includes a component capable of cleaving the label from the conjugate.
Claim 6
Dependent Claim
24 words
The test device of claim 4 in which the label is an enzyme substrate and the compound is an enzyme reactive with the substrate.
Claim 7
Dependent Claim
19 words
The test device of claim 5 in which the label is a β-galactoside moiety and the enzyme is β-galactosidase.
Claim 8
Dependent Claim
18 words
The test device of claim 6 in which the label conjugate is β-galactosyl-umbelliferone-ligand or specific binding analogue thereof.
Claim 9
Independent Claim
182 words
A method for preparing a test device for determining a ligand in, or the ligand binding capacity of, a test sample, the method comprising the sequential steps of incorporating a carrier member with a reagent system in a first solvent, the reagent system being capable of producing a detectable response to the presence of a label conjugate, and including a specific binding partner to the conjugate and a component capable of cleaving the label from the conjugate to produce a detectable response, drying the carrier member, to remove the first solvent cooling the dried carrier member to a temperature sufficient to substantially prevent the component from cleaving the label, further incorporating the carrier member with the label conjugate in a second solvent, the conjugate comprising the label coupled to the ligand or specific binding analogue thereof, the label being a moiety cleavable by the component to produce a detectable response, cooling the carrier member to a temperature sufficient to freeze the second solvent at a rate sufficient to prevent substantial cleavage of the label by the component, and lyophilizing the carrier member.
Claim 10
Independent Claim
182 words
A method for preparing a test device for determining a ligand in, or the ligand binding capacity of, a test sample, the method comprising the sequential steps of incorporating a carrier member with a reagent system in a first solvent, the reagent system being capable of producing a detectable response to the presence of a label conjugate, and including a specific binding partner to the conjugate and a component capable of cleaving the label from the conjugate to produce a detectable response, drying the carrier member, to remove the first solvent cooling the dried carrier member to a temperature sufficient to substantially prevent the component from cleaving the label, further incorporating the carrier member with the label conjugate in a second solvent, the conjugate comprising the label coupled to the ligand or specific binding analogue thereof, the label being a moiety cleavable by the component to produce a detectable response, cooling the carrier member to a temperature sufficient to freeze the second solvent at a rate sufficient to prevent substantial cleavage of the label by the component, and lyophilizing the carrier member.
Claim 11
Dependent Claim
28 words
The method of claim 8 in which the label is a substrate for an enzyme, and the component is the enzyme for which the label is a substrate.
Claim 12
Dependent Claim
29 words
The method of claim 8 in which the ligand is theophylline, the label conjugate is theophylline-umbelliferone-galactose, the component is β-galactosidase and the specific binding partner is antibody to theophylline.
Claim 13
Dependent Claim
18 words
The method of claim 8 in which the label is a β-galactoside moiety and the component is β-galactosidase.
Claim 14
Dependent Claim
16 words
The method of claim 11 in which the label conjugate is β-galactosyl-umbelliferone-ligand or ligand binding analogue.